Parte de monografia/livro

Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers (2020)

• Authors:
  • Farias, Kelen Cristina Ribeiro Malmegrim de
  • Lima Júnior, João Rodrigues
  • Arruda, Lucas Coelho Marliére
  • Azevedo, Júlia Teixeira Cottas de
  • Oliveira, Gislane Lelis Vilela de
  • Rodrigues, Maria Carolina de Oliveira
• USP affiliated authors: FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP ; AZEVEDO, JÚLIA TEIXEIRA COTTAS DE - FMRP
• Unidades: FCFRP; FMRP
• DOI: 10.3389/978-2-88963-472-9
• Subjects: CÉLULAS-TRONCO; TRANSPLANTE DE ÓRGÃOS; DOENÇAS AUTOIMUNES; BIOMARCADORES
• Agências de fomento:
  • Financiamento FAPESP
• Language: Inglês
• Imprenta:
  • Publisher: Frontiers Media
  • Publisher place: Lausanne
  • Date published: 2020
• Source:
  • Título: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
  • Volume/Número/Paginação/Ano: 133 p


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui versão em acesso aberto em repositório (Green Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• URL de acesso aberto
• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	003032539.pdf

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 31 mar. 2026.

• APA

  Farias, K. C. R. M. de, Lima Júnior, J. R., Arruda, L. C. M., Azevedo, J. T. C. de, Oliveira, G. L. V. de, & Rodrigues, M. C. de O. (2020). Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9

• NLM

  Farias KCRM de, Lima Júnior JR, Arruda LCM, Azevedo JTC de, Oliveira GLV de, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2026 mar. 31 ] Available from: https://doi.org/10.3389/978-2-88963-472-9

• Vancouver

  Farias KCRM de, Lima Júnior JR, Arruda LCM, Azevedo JTC de, Oliveira GLV de, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2026 mar. 31 ] Available from: https://doi.org/10.3389/978-2-88963-472-9

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives
• Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
• New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
• Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
• Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?
• Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
• Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy
• Teplizumab in relatives at risk for type 1 diabetes. [Carta]
• New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
• CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]